[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336589-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336589-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","aberrant-hif1-and-six-1-expression-is-associated-with-poor-prognosis-in-acute-myeloid-leukemia-patients-with-isocitrate-dehydrogenase-1-mutations","Aberrant HIF1-α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations","","Background: IDH1 mutations are common across cancers, yet their role in driving the Warburg effect via hypoxia-inducible factor HIF1-α and SIX-1 expression is unclear. Methodology: ARMS-PCR genetic screening in acute myeloid leukemia (AML), brain, and breast cancer cohorts, combined with qPCR for transcript expression, and a meta-analysis of risk factors for the R132 mutation. Results: Mutant IDH1 showed higher disease risk with altered HIF1-α and SIX-1 profiles, linked to poor prognosis and potential prognostic marker value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/aberrant-hif1-and-six-1-expression-is-associated-with-poor-prognosis-in-acute-myeloid-leukemia-patients-with-isocitrate-dehydrogenase-1-mutations/336589/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/aberrant-hif1-and-six-1-expression-is-associated-with-poor-prognosis-in-acute-myeloid-leukemia-patients-with-isocitrate-dehydrogenase-1-mutations/336589.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main focus regarding IDH1 mutations in AML?","Question",{"text":63,"@type":64},"The study examines how mutant IDH1 may regulate HIF1-α and SIX-1 expression and how these changes relate to prognosis in acute myeloid leukemia.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients’ genetic mutations and gene expression measured?",{"text":68,"@type":64},"Genetic screening used ARMS-PCR across AML, brain, and breast cancer cohorts, while transcript expression was determined using qPCR.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings connect altered HIF1-α and SIX-1 levels to prognosis?",{"text":72,"@type":64},"Downregulated HIF1-α and upregulated SIX-1 expression were observed in mutant-IDH1 patients, and perturbed IDH1 and HIF-α levels were associated with poor prognosis in both univariate and multivariate analyses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336589,1791597003,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations  \nCancer Control Volume 31: 1–13  \n© The Author(s) 2024  \nArticle reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/10732748241271714](DOI: 10.1177/10732748241271714)[ ](DOI: 10.1177/10732748241271714)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nTariq Ali, MS 1, Rohma Usman, MS 1, Syed Alasar Shah, MS 1, Aamir Parvez, MD 1, Summayya Anwar, MS 1, Zahid Muneer, PhD 1, and Muhammad Saeed, PhD 1 􀀁  \nAbstract  \nBackground: IDH1 mutations are common in many cancers, however, their role in promoting the Warburg effect remains elusive. This study elucidates the putative involvement of mutant-IDH1 in regulating hypoxia-inducible factor (HIF1-α) and SineOculis Homeobox-1 (SIX-1) expression.  \nMethodology: Genetic screening was performed using the ARMS-PCR in acute myeloid leukemia (AML), brain, and breast cancer (BC) cohorts, while transcript expression was determined using qPCR. Further, a meta-analysis of risk factors associated with the R132 mutation was performed.  \nResults: Approximately 32% of AML and ∼60% of glioma cases were mutants, while no mutation was found in the BC cohort.‘AA’ and TT’ were associated with higher disease risk (OR = 12.18 & 4.68) in AML and had signiﬁcantly upregulated IDH1 expression. Moreover, downregulated HIF1-α and upregulated SIX-1 expression was also observed in these patients, suggesting that mutant-IDH1 may alter glucose metabolism. Perturbed IDH1 and HIF-α levels exhibited poor prognosis in univariate and multivariate analysis, while age and gender were found to be contributory factors as well. Based on the ROC model, these had a good potential to be used as prognostic markers. A signiﬁcant variation in frequencies of R132 mutations in AML among different populations was observed. Cytogenesis (R2 = 12.2%), NMP1 mutation status (R2 = 18.5%), and ethnic contributions (R2 = 73.21%) were critical moderators underlying these mutations. Women had a higher risk of R132 mutation (HR = 1.3, P \u003C 0.04). The pooled prevalence was calculated to be 0.29 (95% CI 0.26-0.33, P \u003C 0.01), indicating that IDH1 mutations are a signiﬁcant prognostic factor in AML.  \nConclusion: IDH1 and HIF1-α proﬁles are linked to poor survival and prognosis, while high SIX-1 expression in IDH1 mutants suggests a role in leukemic transformation and therapy response in AML.  \nPlain Language Summary  \nIDH1 mutations are common in many types of cancer, but scientists have not fully understood how they contribute to the Warburg effect - a process that alters glucose metabolism in cells. In this study, we evaluate the association between mutant-IDH1 and HIF1 as well as SIX-1 gene expression. We analyzed genetic data from patients with brain cancer, breast cancer, and acute myeloid leukemia (AML), and found that roughly 32% of AML cases and 60% of glioma cases had IDH1 mutations, while no mutations were found in breast cancer. Patients with mutant genotypes had a higher risk of disease and  \n1 Cancer Genetics and Epigenetics Lab, Department of Biosciences, COMSATS University Islamabad (CUI), Islamabad, Pakistan  \nCorresponding Author:  \nMuhammad Saeed, Department of Biosciences, COMSATS University Islamabad, Park Road, Tarlai Kalan, Islamabad 45550, Pakistan. [Email:](Email: muhammad.saeed@comsats.edu.pk)[ muhammad.saeed@comsats.edu.pk](Email: muhammad.saeed@comsats.edu.pk)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access pages ([https://us","cbCaiu2JdMpDvJZt","https://ap.wps.com/l/cbCaiu2JdMpDvJZt","pdf",1488117,13,"English","# Abstract\n## Background\n## Methodology\n## Results\n## Conclusion\n# Plain Language Summary\n# Keywords\n# Received, Revised, and Accepted Dates\n# Background\n## IDH Function in Glucose Metabolism","[{\"question\":\"What is the study’s main focus regarding IDH1 mutations in AML?\",\"answer\":\"The study examines how mutant IDH1 may regulate HIF1-α and SIX-1 expression and how these changes relate to prognosis in acute myeloid leukemia.\"},{\"question\":\"How were patients’ genetic mutations and gene expression measured?\",\"answer\":\"Genetic screening used ARMS-PCR across AML, brain, and breast cancer cohorts, while transcript expression was determined using qPCR.\"},{\"question\":\"What key findings connect altered HIF1-α and SIX-1 levels to prognosis?\",\"answer\":\"Downregulated HIF1-α and upregulated SIX-1 expression were observed in mutant-IDH1 patients, and perturbed IDH1 and HIF-α levels were associated with poor prognosis in both univariate and multivariate analyses.\"}]","Aberrant HIF1-α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations | PDF",1790015755,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72e977d19548e5f4b3b50a7e39aa82ac.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e59f0d3a32aa0de32799b028b1a6287.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37f646571db36339ccfdb3ce0d7a1af1.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc5697a79c425741d60ed8527206a849.webp",980,1268]